PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

1. Rehues, P.
2. Girona, J.
3. Guardiola, M.
4. Plana, N.
5. Scicali, R.
6. Piro, S.
7. Muñiz-Grijalvo, O.
8. Díaz-Díaz, J.L.
9. Recasens, L.
10. Pinyol, M.
11. Rosales, R.
12. Esteban, Y.
13. Amigó, N.
14. Masana, L.
15. Ibarretxe, D.
16. Ribalta, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/IJMS24032319 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus